Navigation Links
Crain’s Detroit Business News Names Immunolight LLC Most Innovative Company of 2016

Each year, Crain’s Detroit Business News ranks the most innovative companies through a survey called the Eureka Index – a process that evaluates the patent estate of a company, its impact and significance, and the likelihood of bringing it to market.

Immunolight LLC, a biomedical firm leading the way in technologies that transform energy sources such as low dose X-ray and convert them into energy that is capable of activating a natural compound called psoralen when exposed to UV light, has been named Crain’s Detroit Business News most innovative company for 2016.

Immunolight founder and CEO Rick Bourke has spent the last thirty years dedicated to scientific and medical research. During that time he has developed and supported several medical projects with success in treating cancer and other diseases. Through his research, he conceived the idea of using UV light, generated by energy conversion within the body, along with psoralen to induce an immune response against cancer from inside the tumor.

Psoralen, which is a naturally-occurring compound found in things like celery, figs and citrus fruits, has been aiding in the treatment of autoimmune disease, skin disorders and some forms of cancer for decades, but has not been used in treating solid tumors due to the fact that UV light cannot penetrate tissue.

Through a partnership with Duke University and a team of over thirty scientists, physicians and engineers, led by President Harold Walder, Immunolight is advancing the platform technology by innovating tiny particles that absorb energies that can penetrate tissue and converting them into ultraviolet light inside a tumor to activate psoralen, a known anti-cancer drug.

"Our highest priority is to translate this amazing science into an actual cancer treatment in patients," Walder said. "I think we are quite close."

Immunolight technology has the potential to create a dramatic shift in the treatment of cancer. It wasn’t that long ago that the treatments were limited to three options that included chemotherapy, radiation and surgery. Although improvements have been made in all three areas, cancer remains one of the most grueling diseases that afflict us today in ways that influence us emotionally, physically and financially.

“We have enjoyed a highly productive collaboration with the scientists at Duke and are encouraged by the effects we have seen in cells and in preliminary animal studies. We look forward to moving the technology ahead into patients as a promising new approach to treating solid tumors,” said founder and CEO Rick Bourke.

When can we expect to see Immunolight’s technology trials begin on people? According to Walder, “discussions have begun with the FDA about the requirements to initiate the first human clinical trial.”

“We are honored to be chosen as the most innovative company by Crain’s Detroit Business News,” Walder said, “It is our hope that we can provide an alternative treatment in the fight against cancer with a non-invasive, immune-based treatment that doesn’t involve the cytotoxic agents used in chemotherapy.”

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. ITRA Global’s Detroit Affiliate Awarded Contract to Manage Real Estate for Michigan’s Western and Southeastern Regions
2. Advanced Polymer Monitoring Technologies Adds European Business Development Professional
3. Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business
4. CytoSorbents Receives $318,551 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program
5. Synthorx Appoints Patrick J. Doyle as Chief Business Officer
6. Pfenex Reports Third Quarter 2016 Results and Provides Business Update
7. Amgen Executive Rolf Hoffmann Joins UNC Kenan-Flagler Business School
8. Greater SA Chamber of Commerce Teams Up with South Texas Blood & Tissue Center for the SA Business Challenge competition
9. Gaining Ground: RoviSys Adds Darin Fox as Business Development Manager
10. Software Provider iLab Solutions Named 25th Fastest Growing Company by Boston Business Journal
11. Shimadzu to Showcase Cannabis Testing Technology at Spring 2016 Marijuana Business Expo
Post Your Comments:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):